Summary: Regional cerebral [IIC]3-0-methyl-D-glucose ([IICMeG) uptake kinetics have been measured in five in sulin-dependent diabetic patients and four normal con trols using positron emission tomography (PET), Con comitant measurement of regional cerebral blood volume and CBF enabled corrections for the presence of intra vascular [IICJMeG signal in cerebral regions of interest to be carried out, and regional cerebral [IICJMeG unidirec tional extraction fractions to be computed. Four of the five diabetic subjects were studied with their fasting plasma glucose level clamped at a normoglycaemic level (4 mM), and four were studied at hyperglycaemic plasma glucose levels (mean l3 mM). The four diabetic subjects whose fasting plasma glucose levels were clamped at a normoglycaemic level of 4 mM had mean fasting whole brain, cortical, and white matter [IICJMeG extraction fractions of 15, 15, and 16%, respectively, values similar to those found for the four normal controls (whole brain,
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tions have led to suggestions that there may be a decreased capacity of the blood-brain barrier (BBB) to transport glucose in diabetic subjects (Gjedde and Crone, 1981) , and that the hypotha lamic glucostat for the release of counterregulatory hormones is set at a higher level in diabetic subjects (De Fronzo et aI., 1980) .
Several workers have studied D-glucose transport across the BBB of rats rendered diabetic with streptozotocin (Gjedde and Crone, 1981; McCall et aI., 1982; Di Mattio et aI., 1984) . The first two groups of workers noted a significant reduction in V max for D-glucose in rats that had been hypergly caemic for up to 4 weeks. This suggested that there had been a reduction in the number of carriers for passive facilitated transport of D-glucose across the BBB. The decrease in passive facilitated D-glucose transport in diabetic rats could be abolished by treating them with insulin or by reducing their plasma glucose levels to normal by starvation, sug gesting that hyperglycaemia per se was responsible for the reduction in the number of BBB o-glucose carriers (McCall et aI., 1982; Di Mattio et aI., 1984) .
The aim of this study was to measure regional cerebral o-glucose transport in a group of Type I (insulin-dependent) diabetic patients with poor gly caemic control to see whether cerebral transport of o-glucose was impaired. In our companion article (Brooks et aI., 1986) , it was demonstrated that [ ll C]3-0-methyl-o-glucose ([ ll C]MeG) and positron emission tomography (PET) could be used to study o-glucose transport across the BBB in humans.
[ ll C]MeG is a positron-emitting competitive inhib itor of passive facilitated o-glucose transport across the BBB (Vyska et aI., 1981) . To determine Km values for individual subjects, cerebral [ ll C]MeG uptake at normoglycaemia was compared with that at hyperglycaemia.
METHODS
The glucose clamp technique used in these studies was based on the method of De Fronzo et al. (1979) with mod ifications. A primary dose of insulin (Humulin S; Eli Lilly and Co. Ltd) was given intravenously followed by a con tinuous infusion at a rate of 0.3 mU/kg/min. Arterial plasma glucose was measured at 5-min intervals using the glucose oxidase method (glucose autoanalyser, Beckman). The arterial plasma glucose level was main tained constant with a variable intravenous infusion of 20% dextrose.
In studies of cerebral glucose transport performed on diabetic subjects at hyperglycaemia with undetectable plasma free insulin levels, the insulin infusion was omitted. Plasma glucose levels were again measured at 5-min intervals and prevented from falling with a variable infusion of 20% dextrose. In all studies, plasma free in sulin levels were measured at 20-min intervals. Free in sulin was extracted from total insulin using the method of Kuzuya et al. (1977) . The mean free plasma insulin level resulting from an insulin infusion of 0.3 mU/kg/min used in six of the eight PET studies on diabetic subjects was 48 ± 13 mUlL.
Five normotensive insulin-dependent diabetic subjects aged 23-44 years, 5-23 years since diagnosis, were studied. All had glycosylated hemoglobin A I levels of �9%, confirming a poor previous diabetic control, at the time of PET. Patient details are given in Table I . Four patients were studied at normoglycaemic plasma glucose levels (4 mM) using the glucose clamp technique de scribed above. Patients were asked to omit their last usual dose of long-acting insulin prior to PET, were starved for 4 h, and then were stabilized using the glucose clamp technique 1 h prior to PET scanning. None had symptoms of hypoglycaemia while clamped at normogly caemia. Four patients were also studied at hypergly caemic fasting plasma glucose levels (mean 13 mM). Two of these four (patients 3 and 5) were scanned with unde tectable plasma free insulin present and two (patients 1 and 2) were scanned while insulin was administered intra venously as described previously. In summary, three dia betic patients had double PET studies and two patients had single studies.
Four normal normotensive subjects were studied. Their details are given in Brooks et al. (1986) . All sub jects were studied under resting conditions with their eyes closed. Informed consent was obtained from all subjects prior to PET. This project was approved by the Ethics Committee of the Royal Postgraduate Medical School, Hammersmith Hospital, London, England. Per mission to administer radioactive isotopes was granted by the Administration of Radioactive Substances Advi sory Committee, U.K. ...
DIABETICS
(G=38:t09) Table 2 details the individual extractions and rate constants for regional cerebral ["C]MeG uptake in the diabetic subjects at hyperglycaemia and nor moglycaemia. Table 3 details their mean whole brain ["C]MeG extractions and rate constants. Compared with the controls, mean whole-brain [llC]MeG extraction and the mean whole-brain values of k, and k 2 ' rate constants describing free ["C]MeG transport across the BBB, were all sig nificantly reduced in the hyperglycaemic diabetic subjects. Table 2 shows that the presence of insulin had no apparent effect on the levels of regional ce rebral [ ll C]MeG extraction or k, or k2 values in the hyperglycaemic diabetic patients.
DISCUSSION
The four diabetic subjects studied at normogly caemia showed no significant differences in mean regional cerebral ["C]MeG extractions compared with normal controls. In the companion article (Brooks et aI., 1986) , it is shown that unidirectional ["C]MeG extraction is a function of both the number of o-glucose carriers present in the BBB and the affinity of these carriers for [IIC]MeG. Consequently, the finding that our insulin-treated diabetic subjects had normal levels of regional cere bral [IIC] MeG extraction at normoglycaemia sug gests that they have a normal population of o-glu cose carriers present in their BBB with a normal affinity for o-glucose. When the diabetic subjects were studied during hyperglycaemia, decreased regional cerebral [llC]MeG extractions were observed. This was the case whether their plasma insulin levels were unde tectable or raised by insulin infusion. In Brooks et ai. (1986) , unidirectional extraction of [ l lC]MeG is shown to be an inverse function of the plasma 0-glucose level (Ca). Consequently, the fall in cerebral [l l C]MeG extraction observed for the hypergly caemic diabetic subjects is entirely predictable. From Eq. 4-6 of the companion article if kd' the rate constant for free diffusion of [ l 1 C]MeG across the BBB, is small, it follows that
where Km is the half-saturation constant for o-glu cose transport across the BBB and (2) and (1) refer to hyperglycaemic and normoglycaemic steady state fasting o-glucose parameters, respectively. From Eq. 1 Km can be calculated for the three dia betic subjects who had double PET studies (pa tients 2, 3, and 5) yielding Km values of 6, 3, and II mM. These Km values are in reasonable agreement with the Km values of 6-9 mM obtained for o-glu cose uptake by normal rat, guinea pig, and dog brain (Bachelard, 1971; Betz et aI. , 1973; Pardridge and Oldendorf, 1975) . If the hyperglycaemic group of diabetic patients is compared as a whole with the normoglycaemic group, a mean whole-brain Km of 4.8 mM can be computed for BBB transport of 0-glucose from a comparison of the mean k l values for the two groups.
Our finding of normal [IIC] MeG transport across the BBB in insulin-dependent diabetic subjects is in agreement with animal work. Although V max for glucose transport decreases in chronically hyper glycaemic animals, steptozotocin-induced diabetic animals treated with insulin have normal o-glucose transport (Gjedde and Crone, 1981; McCall et aI. , 1982; Oi Mattio et aI., 1984) . As all our diabetic subjects had been treated with insulin regularly prior to PET, although their glycaemic control was imperfect normal o-glucose transport across their BBB was not unexpected.
Our findings provide no rationale for the symptoms of hypoglycaemia experienced by some normoglycaemic diabetic subjects. At hypergly caemia, mean glucose influx (Ca x k1) was 0.29 mMlmin in the diabetic group, 31 % higher than the influx of 0.22 mMlmin obtained for the normal group. These glucose influx values are in good agreement with those reported in previous studies (Hertz et aI. , 1981) (Table 3) . Glucose influx fell to a normal level in the diabetic group when clamped at normoglycaemia. There is no reason to believe, therefore, that diabetic individuals ever experience neuroglycopaenia while their plasma glucose levels are varying within the normal physiological range.
We have not observed an effect of insulin on [ 11 C]MeG extraction under conditions of hypergly caemia. U sing a double-indicator technique and measuring arteriovenous [14C]o-glucose differ ences, Hertz et ai. (1981) have shown that insulin administration can lead to a 20% rise in unidirec tional o-glucose extraction in normal subjects. These workers, however, used 40 times the level of insulin infusion employed in our studies, producing plasma insulin levels of -1,000 mUlL in a grossly su praphysiological range. The clinical relevance of these workers' findings is therefore questionable.
CONCLUSION
Our treated group of insulin-dependent diabetic patients had normal levels of regional cerebral [lIC]MeG extraction at normoglycaemia (4 mM). At hyperglycaemia their cerebral [IIC] MeG extrac tion fell, as predicted from Michaelis-Menten ki netics, and glucose influx across the BBB in creased. Km values for o-glucose across the BBB calculated for individual diabetic subjects were of the same order of magnitude as those observed in studies on normal animals. No effect of insulin on [IIC]MeG transport across the BBB was demon strated.
